Surgical menopause can feel very different from a gradual menopause transition. When ovarian hormone production stops suddenly, symptoms may arrive quickly and feel more intense. For some people, one of the most distressing changes is a sudden loss of sexual desire or sexual response.
This does not mean testosterone is always the answer. After surgery or ovarian treatment, low libido can be linked to oestrogen loss, vaginal dryness or pain, sleep disruption, mood, body confidence, recovery from surgery, relationship strain, medication, cancer treatment, or fear around sex and symptoms.
Important
This article is for general information only. Surgical menopause, cancer-related menopause and risk-reducing surgery need individual advice. Your own surgeon, gynaecologist, oncology team, GP or menopause specialist may need to be involved depending on your history.
What does surgical menopause mean?
Surgical menopause usually occurs when both ovaries are removed during an operation, causing hormone levels to fall suddenly. It can also occur if ovarian function stops following certain medical treatments.
This is different from a hysterectomy, which is an operation to remove the womb (uterus). During a hysterectomy, one or both ovaries may be left in place. If they are, they usually continue to produce hormones, although some women experience an earlier decline in ovarian function after surgery.
What does a hysterectomy mean?
A hysterectomy is an operation to remove the uterus (womb). It may be performed for a range of reasons, including heavy menstrual bleeding, fibroids, endometriosis, adenomyosis or some gynaecological cancers.
A hysterectomy does not always cause menopause. If one or both ovaries are left in place, they usually continue to produce hormones. However, some women experience an earlier decline in ovarian function after surgery, so menopausal symptoms may develop sooner than expected.
| Situation | What it may mean for hormones | Why symptoms may differ |
|---|---|---|
| Both ovaries removed | Ovarian oestrogen and testosterone production falls abruptly. | Menopause symptoms and sexual changes may appear suddenly. |
| Hysterectomy with ovaries retained | The womb is removed, but ovarian hormones may continue for some time. | You will not have periods, so menopause timing may be harder to recognise. |
| One ovary removed | The remaining ovary may continue hormone production. | Symptoms vary and are not always the same as surgical menopause after both ovaries are removed. |
| Ovarian function affected by treatment | Chemotherapy, radiotherapy or hormone-blocking treatment may reduce or stop ovarian function. | Symptoms and treatment options depend on the reason for treatment and specialist advice. |
Why can symptoms change so suddenly?
Before menopause, the ovaries produce oestrogen and testosterone as part of normal female physiology. They are not the only source of hormones, because the adrenal glands and other tissues also contribute, but the ovaries are an important part of the picture.
When both ovaries are removed, ovarian oestrogen production falls suddenly. Testosterone production can also fall, and this change may be more abrupt than the gradual age-related decline many people experience over time.
This sudden change can affect more than one part of sexual wellbeing. Some people notice low desire. Others notice less arousal, reduced sexual response, vaginal dryness, pain, sleep changes, mood changes or a more general sense that their body feels different.
Why has my libido changed after surgery?
Low libido after surgical menopause can have more than one cause. Sometimes desire itself feels absent. Sometimes desire is still there, but the body starts to avoid sex because it has become uncomfortable, painful or emotionally loaded.
-
Desire and arousal
You may have fewer sexual thoughts, less interest in intimacy, or less response to touch or stimulation. This can feel upsetting, especially if the change is sudden.
-
Vaginal comfort
Lower oestrogen can affect vaginal and vulval tissues, leading to dryness, irritation, burning, discomfort during sex or recurrent urinary symptoms.
-
Sleep and mood
Hot flushes, night sweats, poor sleep, anxiety, low mood or recovery stress can all reduce interest in intimacy.
-
Confidence and body image
Surgery, scars, cancer treatment, early menopause, pain or feeling disconnected from your body can affect confidence and sexual wellbeing.
Why symptoms still need a full assessment
It can be tempting to assume that low libido after ovary removal must mean low testosterone. In reality, symptoms alone cannot diagnose the cause. A blood result alone cannot explain desire either.
A good assessment should look at the whole picture, including:
- the type of surgery or treatment you had and when it happened
- whether one, both or neither ovary was removed
- your current HRT, dose, route and how consistently it is being used
- whether vaginal dryness, pain or urinary symptoms are present
- sleep, hot flushes, mood, anxiety, stress and recovery from surgery
- medication that may affect desire, arousal or orgasm
- relationship, confidence, body image and psychosexual factors
- medical history, including cancer history, endometriosis, liver disease or clotting risk
- baseline total testosterone and any other blood tests clinically needed
This is not about dismissing testosterone. It is about making sure treatment is safe, targeted and realistic.
Does oestrogen or vaginal treatment need reviewing first?
For many people after surgical menopause, oestrogen replacement is the first part of treatment to review where it is clinically appropriate. Oestrogen can help with hot flushes, night sweats, sleep disruption, mood symptoms and vaginal or urinary symptoms linked to menopause.
If vaginal dryness, irritation, burning, painful sex or recurrent urinary symptoms are present, local vaginal treatment may also be needed. This may include vaginal oestrogen, vaginal moisturisers, lubricants, Intrarosa where clinically appropriate, pelvic-floor support or further assessment if symptoms are persistent or unusual.
Key point
Testosterone is not a treatment for vaginal pain or dryness itself. If sex hurts, treating the pain and vaginal symptoms is often an essential first step, even if testosterone is later considered for persistent low desire.
HRT review may include whether your oestrogen dose is adequate, whether the route suits you, whether symptoms have had enough time to respond, whether you are using treatment consistently, and whether vaginal symptoms need separate local support.
When may testosterone be considered after a hysterectomy or surgical menopause?
Testosterone may be considered when there is persistent low sexual desire associated with menopause that is causing personal distress, after other relevant factors have been reviewed and HRT has been tried or optimised where appropriate.
This may be particularly relevant after surgical menopause because ovarian testosterone production can change abruptly. However, it is still not automatic. Some people do not need testosterone, some do not respond, and some may not be suitable because of their medical history or current symptoms.
If testosterone is discussed, it should usually be framed as a monitored trial with clear goals, rather than an indefinite treatment started without review.
Cancer treatment and risk-reducing surgery
Some people enter surgical or treatment-related menopause because of cancer treatment, endometriosis surgery, BRCA-related risk-reducing surgery or another complex gynaecological reason. This can feel emotionally and physically difficult, especially if menopause happened earlier than expected.
Suitability for HRT, vaginal oestrogen, Intrarosa or testosterone depends on the type of cancer or risk history, treatment received, current medication and specialist advice. Breast cancer, hormone-sensitive cancer, complex endometriosis and some risk-reducing surgery pathways may require input from oncology, gynaecology or a specialist menopause service.
Safety note
Do not assume testosterone, HRT or vaginal treatment is suitable or unsuitable based only on a general article. If your menopause followed cancer treatment or risk-reducing surgery, individual specialist advice is essential.
Baseline testing, monitoring and realistic outcomes
If testosterone is considered, baseline blood testing is used to support safe prescribing. This usually includes total testosterone before treatment to establish a baseline and to check levels are not already high. Monitoring during treatment helps keep levels within the female physiological range and supports repeat-prescribing decisions.
Blood tests are only one part of the review. Your clinician should also ask whether desire, arousal, sexual response and distress have changed, whether vaginal symptoms or pain are still present, whether side effects have developed and whether the treatment still feels worthwhile.
Benefits are not instant. A fair trial is usually assessed over months rather than days or weeks. If there is no meaningful benefit after an appropriate monitored trial, treatment may be stopped or the wider picture reviewed again.
When might treatment be continued, adjusted or stopped?
After review, your clinician may discuss continuing testosterone if there is meaningful benefit, levels remain within range and side effects are not problematic. They may discuss adjustment if symptoms are improving but side effects, blood results, application technique, formulation or HRT need review.
Treatment may be stopped if there is no meaningful benefit, testosterone levels are too high, androgenic side effects develop, your medical situation changes, or the balance of benefit and risk no longer feels right.
Please do not increase, reduce, switch or stop testosterone without speaking to your prescriber, unless you have been advised to stop urgently because of a significant reaction.
How LIVVE assesses the whole picture
LIVVE’s approach is to understand what changed, when it changed and what else may be contributing. That means looking at your surgery or treatment history, current HRT, vaginal and urinary symptoms, sexual desire and distress, medication, sleep, mood, relationship factors, blood tests and safety considerations.
Where testosterone is appropriate, LIVVE can explain the available treatment options at overview level and direct you to detailed product guidance. No specific formulation is automatically preferred after surgery; the right option depends on assessment, safety, monitoring, availability, practical use and shared decision-making.
Book a specialist menopause and testosterone assessment
If your libido, arousal, vaginal comfort or wellbeing changed after ovary removal or treatment-related menopause, LIVVE can help review the full picture and explain whether testosterone is appropriate.
